Who owns Acorda Therapeutics?

Key details on Acorda Therapeutics (Ticker: ACOR)

Who owns Acorda Therapeutics?

Is ACOR a good stock to own? Find out who bought Acorda Therapeutics, who sold Acorda Therapeutics (ACOR) stock, and who holds a large position in Acorda Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 4.28M $162.34M March 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 3.23M $109.36M Sept. 30, 2014
Vanguard 2.78M $93.78M June 30, 2014
Adage Capital Partners GP 2.71M $64.60M Dec. 31, 2011
BlackRock Fund Advisors 2.60M $88.10M Sept. 30, 2014
Damian Sousa 2.47M $83.77M Sept. 30, 2014
Oracle Investment Management 1.93M $65.11M June 30, 2014
Invus Public Equities Advisors 1.70M $54.93M June 30, 2011
Bridger Management 1.50M $39.83M March 31, 2012
STATE STREET CORPORATION 1.31M $44.32M June 30, 2014
Ulys 1.30M $34.52M March 31, 2012
Inves 1.25M $47.48M March 31, 2014
Wellington Management Company 1.23M $41.46M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.19M $40.43M Sept. 30, 2014
GOLDMAN SACHS 1.16M $43.80M March 31, 2014
Artal Group S.A. 1.10M $37.45M Sept. 30, 2013
Thompson, Siegel, & Walmsley 1.05M $30.73M Dec. 31, 2013
Barclays 1.04M $24.75M Dec. 31, 2011
BlackRock Advisors 1.03M $35.32M Sept. 30, 2013
ClearBridge Advisors 1.00M $33.75M June 30, 2014
Baker Bros. Advisors 1000000 $37.91M March 31, 2014
Camber Capital Management 1000000 $26.55M March 31, 2012

Who sold Acorda Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Name Passport Capital Sept. 30, 2011 1.11M $22.20M
Millennium Management Sept. 30, 2011 963767 $19.24M
S.A.C. Capital Advisors June 30, 2011 2.36M $76.31M
Brookside Capital Management, LLC* June 30, 2011 1.39M $44.78M
Wells Fargo & Company March 31, 2011 2.34M $53.62M
Westfield Capital Management Company Dec. 31, 2010 1.77M $48.24M
Senator Investment Dec. 31, 2010 1.23M $33.39M
Columbia Wanger Asset Management Dec. 31, 2010 1.17M $31.91M